Assessment of phosphatidylinositol-3 kinase (PI3K) as a prognostic marker in head and neck squamous cell carcinoma (HNSCC)

被引：1
|
作者：
Pectasides, E.
Founztilas, G.
Sasaki, C.
Burtness, B.
Psyrri, A.
机构：
[1] Yale Univ, New Haven, CT USA
[2] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece
[3] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17028
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Evaluation of the prognostic significance of activated STAT3 expression levels in head and neck squamous cell carcinoma (HNSCC)
    Pectasides, E.
    Kountourakis, P.
    Fountzilas, G.
    Burtness, B. A.
    Psyrri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] HS-173, a selective PI3K inhibitor, induces cell death in head and neck squamous cell carcinoma cell lines
    Foki, Elisabeth
    Stanisz, Isabella
    Kadletz, Lorenz
    Kotowski, Ulana
    Seemann, Rudolf
    Schmid, Rainer
    Heiduschka, Gregor
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (1-2) : 26 - 31
  • [43] Assessing the role of phosphoinositide 3-kinase (PI3K) in head and neck cancers
    Shen, W.
    El Dinali, M.
    Braegelmann, J.
    Zoergiebel, J.
    Kundu, A.
    El-Hashani, E.
    Salgia, R.
    Seiwert, T.
    EJC SUPPLEMENTS, 2010, 8 (07): : 66 - 66
  • [44] Acetylated Tubulin (AT) as a Prognostic Marker in Squamous Cell Carcinoma of the Head and Neck
    Saba N.F.
    Magliocca K.R.
    Kim S.
    Muller S.
    Chen Z.
    Owonikoko T.K.
    Sarlis N.J.
    Eggers C.
    Phelan V.
    Grist W.J.
    Chen A.Y.
    Ramalingam S.S.
    Chen Z.G.
    Beitler J.J.
    Shin D.M.
    Khuri F.R.
    Marcus A.I.
    Head and Neck Pathology, 2014, 8 (1) : 66 - 72
  • [45] FRZB: a potential prognostic marker for head and neck squamous cell carcinoma
    Li, Yunshan
    Gu, Feihan
    Huang, Xu
    Huang, Wenkai
    Xiang, Junwei
    Yue, Jiayuan
    Wang, Yuanyin
    Chen, Ran
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2024, 57
  • [46] Prognostic impact of comorbidity in elderly patients with head and neck squamous cell carcinoma (HNSCC)
    Moreno Jimenez, M. A.
    Gonzalez Cebrian, I.
    Collado Martin, R.
    Medina Magan, B.
    Ortega Granados, A. L.
    Mateos Salido, M. J.
    Alonso Calderon, R.
    Plata, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 480 - 480
  • [47] Expression of p16 as a prognostic marker in head and neck squamous cell carcinomas (HNSCC).
    Le, QT
    Koong, AC
    Pinto, HA
    Giaccia, AJ
    Kong, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 505S - 505S
  • [48] New drug development in head and neck squamous cell carcinoma: The PI3-K inhibitors
    De Felice, Francesca
    Urbano, Teresa Guerrero
    ORAL ONCOLOGY, 2017, 67 : 119 - 123
  • [49] IDENTIFICATION OF A LOW PHOSPHATASE AND TENSIN HOMOLOG (PTEN) HIGH PHOSPHATIDYLINOSITOL-3 KINASE (PI3K) β EXPRESSING SUBSET OF SQUAMOUS NON-SMALL-CELL LUNG CANCER (NSCLC)
    Cumberbatch, Marie
    Tang, Xi Ming
    Beran, Garry
    Luke, S.
    Singh, P.
    Kvist, A.
    Cosulich, Sabina
    Smith, Paul D.
    Behrens, Carmen
    Kim, Edward
    Warren, Madhuri
    Womack, Chris
    Gray, Neil
    Wistuba, Ignacio
    Blowers, David P.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S446 - S446
  • [50] Osthole induces cell cycle arrest and apoptosis in head and neck squamous cell carcinoma by suppressing the PI3K/AKT signaling pathway
    Yang, Jing
    Zhu, Xin-jiang
    Jin, Ming-zhu
    Cao, Zhi-wei
    Ren, Yao-yao
    Gu, Zhao-wei
    CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 316
12345